Supplier News

The collaboration will focus on development of novel molecules using SMARTag technology to couple different therapeutic modalities.

Charles River Laboratories entered into a definitive agreement to acquire WIL Research.

The company’s new version of its glycan analysis tool will help investigators determine the relative abundance of individual N-glycan structures in small biopharmaceutical samples.

AMRI adds analytical capabilities to its outsourcing services offerings with the acquisition of Whitehouse Labs.

Grand River Aseptic Manufacturing expands disposable technology capabilities at aseptic facility.

Vetter receives AEO-F certificate from the European Union for global movement of goods.

The portal is an interactive tool that pulls together the innovation landscape, company base, and manufacturing sites for the entire medicines sector in the UK.

The University of Sheffield has appointed Cobra Biologics to advance novel fusion protein technology into Phase 1 clinical trials.

Expansions at Catalent’s Kansas City, MO, and Madison, WI facilities made in response to industry demand.

Baxter expands capacity for lyophilized cytotoxic oncology therapies at its fill/finish facility in Halle, Germany.

Thermo Fisher Scientific announced the opening of their new GMP clinical services facility in Singapore.

Charles River Laboratories announces the acquisition of Oncotest GmbH.

Baxter expands capacity for lyophilized cytotoxic oncology therapies at its fill/finish facility in Halle, Germany.

Merck KGaA announces the completion of the acquisition of Sigma-Aldrich, a St. Louis-based life-sciences and technology company.

BioOutsource releases informational video detailing issues associated with ADCC assays and how to effectively analyze them.

The UK’s National Biologics Manufacturing Centre will use Novasep’s BioSC Lab for protein purification.

GE Healthcare's KUBio prebuilt modules were shipped from Germany to JHL Biotech in Wuhan, China.

The company said its DevClin business will continue to be an integral part of its long-term biologics business growth strategy.

The new IVIG products boast improvements in purity, safety, and yield.

The testing laboratory will add capacity to strengthen its early-stage drug research capabilities for its small and large biotech clients.

According to Bio-Rad executives, the company’s adoption of its ERP system has created a backlog of projects.

Biovest’s mAbVault provides supply-chain redundancy for antibodies that enables customers to lock in price-per-gram protein production.

Flexsafe 3D Pre-Designed Solutions feature appropriate components, functionalities, and quality controls that meet the specific requirements of each step in upstream and downstream processing and in final filling.

Merck relaunches brand identity to reflect transformation into a science and technology company.

Scottish injectable-drug manufacturer Symbiosis Pharmaceutical Services plans to expand its sterile filling facility.

Avantor released a packaging platform that allows for the direct dispensing of chemicals-such as salts, buffers, and cell culture ingredients-into processing equipment.

The process provides an alternative to the sterilization of cartridges and vials with ethylene oxide (EtO).

Hiroaki Suzuki will lead Vetter’s business activities in the new Tokyo-based office.

Althea is expanding its existing biological drug product manufacturing operations to include highly active materials, such as antibody-drug conjugates, in a new facility near San Diego, CA.